ストックスクリーナーアプリを入手
2.715
5.40%
-0.155
前日終値:
$2.87
開ける：
$2.9
24時間の取引高:
2.71M
Relative Volume:
0.72
時価総額：
$627.25M
収益：
-
当期純損益:
$-179.82M
株価収益率:
-2.0414
EPS:
-1.33
ネットキャッシュフロー:
$-159.16M
1週間 パフォーマンス:
+7.74%
1か月 パフォーマンス:
-17.35%
6か月 パフォーマンス:
+45.19%
1年 パフォーマンス:
+206.47%
1日の値動き範囲:
$2.67
$2.92
1週間の範囲:
$2.38
$2.999
52週間の値動き範囲:
$0.76
$3.87
Gossamer Bio Inc Stock (GOSS) Company Profile
GOSS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GOSS
Gossamer Bio Inc
|
2.71 | 664.28M | 0 | -179.82M | -159.16M | -1.33 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.56 | 118.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
751.87 | 79.40B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
816.00 | 51.18B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
362.87 | 48.88B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
339.26 | 37.49B | 4.98B | 69.59M | 525.67M | 0.5197 |
Gossamer Bio Inc Stock (GOSS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-10 | アップグレード | UBS | Neutral → Buy |
| 2025-07-14 | 開始されました | Scotiabank | Sector Outperform |
| 2024-06-25 | 開始されました | Oppenheimer | Outperform |
| 2024-04-05 | 再開されました | Wedbush | Outperform |
| 2023-07-27 | ダウングレード | UBS | Buy → Neutral |
| 2023-03-07 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2023-03-01 | 開始されました | Guggenheim | Neutral |
| 2022-12-07 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2022-12-07 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2022-12-07 | ダウングレード | SMBC Nikko | Outperform → Neutral |
| 2022-10-20 | 開始されました | Goldman | Buy |
| 2022-09-21 | 開始されました | JP Morgan | Neutral |
| 2022-09-19 | 開始されました | Wedbush | Outperform |
| 2022-04-18 | 開始されました | Raymond James | Outperform |
| 2022-04-06 | 開始されました | UBS | Buy |
| 2022-01-10 | アップグレード | SMBC Nikko | Neutral → Outperform |
| 2021-11-09 | 再開されました | Cantor Fitzgerald | Overweight |
| 2021-09-21 | 再開されました | Piper Sandler | Overweight |
| 2020-06-29 | 開始されました | H.C. Wainwright | Buy |
| 2020-04-22 | 開始されました | Piper Sandler | Overweight |
| 2020-02-27 | 開始されました | Barclays | Overweight |
| 2019-12-03 | 再開されました | BofA/Merrill | Buy |
| 2019-10-30 | 開始されました | Berenberg | Buy |
| 2019-03-05 | 開始されました | Barclays | Overweight |
| 2019-03-05 | 開始されました | BofA/Merrill | Buy |
| 2019-03-05 | 開始されました | Evercore ISI | Outperform |
| 2019-03-05 | 開始されました | SVB Leerink | Outperform |
すべてを表示
Gossamer Bio Inc (GOSS) 最新ニュース
Cantor Fitzgerald reiterates Overweight rating on Gossamer Bio stock By Investing.com - Investing.com Nigeria
H.C. Wainwright reiterates Buy rating on Gossamer Bio stock ahead of key trial By Investing.com - Investing.com India
Cantor Fitzgerald reiterates Overweight rating on Gossamer Bio stock - Investing.com
Gossamer Bio (NASDAQ:GOSS) Given Buy Rating at HC Wainwright - MarketBeat
H.C. Wainwright reiterates Buy rating on Gossamer Bio stock ahead of key trial - Investing.com
GOSS: HC Wainwright & Co. Reiterates Buy Rating with $10 Price T - GuruFocus
With 63% institutional ownership, Gossamer Bio, Inc. (NASDAQ:GOSS) is a favorite amongst the big guns - Yahoo Finance
Gossamer Bio, Inc.'s (NASDAQ:GOSS) Popularity With Investors Under Threat As Stock Sinks 27% - simplywall.st
Gossamer Bio Inc Just Went Wild: Is This Tiny Biotech the Next Viral Moonshot or Total Trap? - AD HOC NEWS
Aug Spikes: How does Napco Security Technologies Inc score in quality rankingsTrade Volume Summary & Safe Capital Allocation Plans - baoquankhu1.vn
Pullback Watch: What are the risks of holding ProShares Trust ProShares Short MSCI Emerging MarketsWeekly Market Summary & Expert Approved Trade Ideas - baoquankhu1.vn
Gossamer Bio (NASDAQ:GOSS) Trading Down 4.7%Time to Sell? - MarketBeat
Gossamer Bio, Inc. (NASDAQ:GOSS) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
What is the fair value of Gossamer Bio Inc. stock nowTrade Exit Summary & Smart Investment Allocation Tips - Улправда
Is Gossamer Bio Inc. stock trading at a premium valuation2025 Winners & Losers & High Accuracy Investment Signals - Улправда
Gossamer Bio, Inc. (GOSS): Analyst Ratings Highlight a Significant 294% Upside for Biotech Investors - DirectorsTalk Interviews
How Gossamer Bio Inc. (4GB) stock reacts to stronger dollarTrade Analysis Report & AI Powered Market Entry Ideas - Улправда
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - MarketScreener
Biotech Gossamer Bio gives new hires a stake with long-term stock options - Stock Titan
Can Gossamer Bio Inc. stock hit record highs againJuly 2025 Macro Moves & Weekly Setup with High ROI Potential - Улправда
Gossamer Bio Sees Unusually High Options Volume (NASDAQ:GOSS) - Defense World
Gossamer Bio Sees Unusually Large Options Volume (NASDAQ:GOSS) - MarketBeat
Gossamer Bio Currently Down Eight Consecutive Days, on Pace for Longest Losing Streak Since November 2024 -- Data Talk - 富途牛牛
Gossamer Bio (NASDAQ:GOSS) Shares Down 6.8%What's Next? - MarketBeat
The Truth About Gossamer Bio Inc (GOSS): Tiny Stock, Massive Drama – Is It Worth the Hype? - AD HOC NEWS
Gossamer Bio (NASDAQ:GOSS) Stock Price Down 3.6%What's Next? - MarketBeat
Gossamer Bio Inc 4GB Stock Analysis and ForecastHigh Dividend Yield Stocks & Free Expert Stock Watchlists - earlytimes.in
10 Health Care Stocks Whale Activity In Today's Session - Benzinga
Gossamer Bio (GOSS) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Gossamer Bio: Market Moves and Future Prospects - StocksToTrade
Gossamer Bio (NASDAQ:GOSS) Stock Price Down 4.1%Should You Sell? - MarketBeat
Gossamer Bio (NASDAQ:GOSS) Shares Up 9.2%Here's Why - MarketBeat
Gossamer Bio, Inc.(NasdaqGS: GOSS) added to S&P Biotechnology Select Industry Index - marketscreener.com
Gap Down: Will Timberland Bancorp Inc stock outperform Nasdaq indexJuly 2025 Earnings & Low Volatility Stock Recommendations - moha.gov.vn
Gossamer Bio (GOSS) Sees Strong Analyst Confidence Amid Seralutinib Progress and Upcoming PROSERA Data - Finviz
Corient Private Wealth LLC Purchases 302,200 Shares of Gossamer Bio, Inc. $GOSS - MarketBeat
Aug Decliners: Can Gossamer Bio Inc. stock deliver surprise earnings beatWeekly Profit Recap & Expert Curated Trade Setups - Улправда
Is Gossamer Bio Inc. stock attractive for income investorsJuly 2025 Closing Moves & Free Weekly Watchlist of Top Performers - DonanımHaber
Gossamer Bio: High Risk Binary Approaches (NASDAQ:GOSS) - Seeking Alpha
Will Gossamer Bio Inc. stock reach Wall Street targetsJuly 2025 Highlights & Low Risk High Reward Ideas - DonanımHaber
Gossamer Bio, Inc. (NASDAQ:GOSS) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Can Gossamer Bio Inc. stock deliver surprise earnings beatJuly 2025 Setups & Free Daily Entry Point Trade Alerts - Улправда
Gossamer Bio (NASDAQ:GOSS) Sets New 1-Year HighShould You Buy? - MarketBeat
Gossamer Bio (NASDAQ:GOSS) Stock Price Down 6.5%Time to Sell? - MarketBeat
Oppenheimer Confident in Positive PROSERA Trial Readout in February 2026 for Gossamer Bio (GOSS) - Finviz
Gossamer Bio (NASDAQ:GOSS) Stock Price Up 5.1%Here's What Happened - MarketBeat
20 Stocks That Will Double in 2026 - Insider Monkey
Gossamer Bio (NASDAQ:GOSS) Hits New 52-Week HighShould You Buy? - MarketBeat
Gossamer Bio, Inc. (GOSS) Stock Analysis: A Biotech Contender with a 172% Potential Upside - DirectorsTalk Interviews
Gossamer Bio announces inducement grant under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Gossamer Bio Inc (GOSS) 財務データ
収益
当期純利益
現金流量
EPS
3.31%
2.06%
大文字化:
|
ボリューム (24 時間):